BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38265207)

  • 1. Genomic description of acquired fluconazole- and echinocandin-resistance in patients with serial
    Misas E; Seagle E; Jenkins EN; Rajeev M; Hurst S; Nunnally NS; Bentz ML; Lyman MM; Berkow E; Harrison LH; Schaffner W; Markus TM; Pierce R; Farley MM; Chow NA; Lockhart SR; Litvintseva AP
    J Clin Microbiol; 2024 Feb; 62(2):e0114023. PubMed ID: 38265207
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Al-Baqsami ZF; Ahmad S; Khan Z
    Sci Rep; 2020 Apr; 10(1):6238. PubMed ID: 32277126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low level of antifungal resistance of Candida glabrata blood isolates in Turkey: Fluconazole minimum inhibitory concentration and FKS mutations can predict therapeutic failure.
    Arastehfar A; Daneshnia F; Salehi M; Yaşar M; Hoşbul T; Ilkit M; Pan W; Hagen F; Arslan N; Türk-Dağı H; Hilmioğlu-Polat S; Perlin DS; Lass-Flörl C
    Mycoses; 2020 Sep; 63(9):911-920. PubMed ID: 32413170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and antimicrobial resistance of vaginal Candida glabrata isolates in Namibia.
    Dunaiski CM; Kock MM; Chan WY; Ismail A; Peters RPH
    Med Mycol; 2024 Jan; 62(2):. PubMed ID: 38308518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and susceptibility of Nakaseomyces (formerly Candida) glabrata bloodstream isolates from hospitalised adults in South Africa.
    Naicker SD; Shuping L; Zulu TG; Mpembe RS; Mhlanga M; Tsotetsi EM; Maphanga TG; Govender NP;
    Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37336590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata.
    Pfaller MA; Castanheira M; Lockhart SR; Ahlquist AM; Messer SA; Jones RN
    J Clin Microbiol; 2012 Apr; 50(4):1199-203. PubMed ID: 22278842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
    Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
    Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance.
    Pham CD; Iqbal N; Bolden CB; Kuykendall RJ; Harrison LH; Farley MM; Schaffner W; Beldavs ZG; Chiller TM; Park BJ; Cleveland AA; Lockhart SR
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4690-6. PubMed ID: 24890592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata.
    Singh-Babak SD; Babak T; Diezmann S; Hill JA; Xie JL; Chen YL; Poutanen SM; Rennie RP; Heitman J; Cowen LE
    PLoS Pathog; 2012; 8(5):e1002718. PubMed ID: 22615574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
    Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China.
    Li Y; Hou X; Li R; Liao K; Ma L; Wang X; Ji P; Kong H; Xia Y; Ding H; Kang W; Zhang G; Li J; Xiao M; Li Y; Xu Y
    BMC Microbiol; 2023 Nov; 23(1):341. PubMed ID: 37974063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Level of Antifungal Resistance in Iranian Isolates of Candida glabrata Recovered from Blood Samples in a Multicenter Study from 2015 to 2018 and Potential Prognostic Values of Genotyping and Sequencing of
    Arastehfar A; Daneshnia F; Zomorodian K; Najafzadeh MJ; Khodavaisy S; Zarrinfar H; Hagen F; Zare Shahrabadi Z; Lackner M; Mirhendi H; Salehi M; Roudbary M; Pan W; Kostrzewa M; Boekhout T
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30936110
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Bordallo-Cardona MÁ; Agnelli C; Gómez-Nuñez A; Sánchez-Carrillo C; Bouza E; Muñoz P; Escribano P; Guinea J
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.
    Beyda ND; John J; Kilic A; Alam MJ; Lasco TM; Garey KW
    Clin Infect Dis; 2014 Sep; 59(6):819-25. PubMed ID: 24879785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to echinocandin antifungal agents in the United Kingdom in clinical isolates of Candida glabrata: Fifteen years of interpretation and assessment.
    Fraser M; Borman AM; Thorn R; Lawrance LM
    Med Mycol; 2020 Feb; 58(2):219-226. PubMed ID: 31111912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.
    Khalifa HO; Arai T; Majima H; Watanabe A; Kamei K
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32571826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidemia surveillance in Iowa: emergence of echinocandin resistance.
    Matsumoto E; Boyken L; Tendolkar S; McDanel J; Castanheira M; Pfaller M; Diekema D
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):205-8. PubMed ID: 24666704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased echinocandin susceptibility in
    Ning Y; Xiao M; Perlin DS; Zhao Y; Lu M; Li Y; Luo Z; Dai R; Li S; Xu J; Liu L; He H; Liu Y; Li F; Guo Y; Chen Z; Xu Y; Sun T; Zhang L
    Emerg Microbes Infect; 2023 Dec; 12(1):2153086. PubMed ID: 36440795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.